Ensite Navx三维标测系统引导下射频消融术治疗右侧旁道57例效果观察

发布时间：2018-05-20 22:28

本文选题：右侧旁道 + 射频消融术　；参考：《山东医药》2017年41期

【摘要】：目的探讨Ensite Navx三维标测系统指导下射频消融术(RFCA)治疗右侧旁道(RAP)的效果。方法选取接受RFCA治疗的111例RAP患者,将其分为观察组57例及对照组54例,观察组于Ensite Navx引导下行RFCA,对照组于传统X线下行RFCA。比较两组放置标测导管过程中X线照射时间和曝光剂量、操作消融导管进行标测消融过程中X线照射时间和曝光剂量、手术时间、即刻成功率、并发症等。结果观察组、对照组放置标测导管过程中X线照射时间分别为(2.2±1.2)、(2.3±1.1)min,曝光剂量分别为(1.5±1.1)、(1.4±1.0)m Gy,两组比较,P均0.05。观察组、对照组消融导管操作过程中X线照射时间分别为(2.3±1.2)、(14.2±3.5)min,X线曝光剂量分别为(2.5±1.0)、(18.9±5.6m)m Gy,两组比较,P均0.05。观察组、对照组手术全程X线照射时间分别为(5.3±2.9)、(16.8±4.2)min,总曝光剂量分别为(6.1±3.1)、(19.6±5.4)m Gy,两组比较,P均0.05。观察组、对照组手术时间分别为(43.9±13.6)、(54.9±15.7)min,两组比较,P0.05。两组均消融成功,术后随访3个月无复发病例。术中两组均未出现相关并发症。结论 Ensite Navx三维标测系统指导下RFCA治疗RAP的效果较好,可在一定程度上缩短总手术时间及曝光剂量,不增加手术相关并发症的发生风险。
[Abstract]:Objective to investigate the effect of radiofrequency ablation (RFCA) guided by Ensite Navx three-dimensional mapping system in the treatment of right accessory pathway (AP). Methods 111 patients with RFCA were divided into observation group (n = 57) and control group (n = 54). The observation group was guided by Ensite Navx and the control group was treated with conventional X-ray. The X-ray irradiation time and exposure dose during catheter placement were compared between the two groups, and X-ray irradiation time and exposure dose, operation time, immediate success rate and complications were measured by ablation catheter mapping. Results in the observation group, the X-ray irradiation time and the exposure dose were 2.2 卤1.2 卤1.2 卤1.1 min and 1.4 卤1.0 mGy, respectively, in the control group. The comparison was made between the two groups (P < 0.05). In the observation group, the time of X-ray irradiation during catheter ablation in the control group was 2.3 卤1.2 min ~ (-1) and 14.2 卤3.5 min ~ (-1), respectively. The exposure dose of X ray in the control group was (2.5 卤1.0) min ~ (-1) (18.9 卤5.6m)m ~ (-1) Gy), respectively, and the two groups were compared with each other (P < 0.05). In the observation group, the total exposure dose was 19.6 卤5.4mGy and the total exposure dose was 6.1 卤3.1mGy, respectively. The X-ray irradiation time of the control group was 5.3 卤2.9g / min, respectively, and the total exposure dose was 0.05g / min. The results were as follows: (1) in the control group, the total exposure dose was 19.6 卤5.4mGy (P = 0.05). In the observation group, the operative time in the control group was 43.9 卤13.6 min, respectively, 54.9 卤15.7min, compared with P0.05in the two groups. Ablation was successful in both groups, and no recurrence occurred after 3 months follow-up. There were no related complications in both groups. Conclusion RFCA under the guidance of Ensite Navx three-dimensional mapping system is effective in the treatment of RAP. It can shorten the total operative time and exposure dose to some extent and does not increase the risk of complications associated with surgery.
【作者单位】：新疆医科大学;新疆医科大学附属中医医院·新疆维吾尔自治区中医药研究院;
【分类号】：R541.7

【相似文献】